Confluence Score · Biotechnology
VRTX
Vertex Pharmaceuticals Inc.
Confluence Score
56/100
Neutral
Updated 2026-09-06 · Limited Coverage
1
Bullish Signals
1
Bearish Signals
1
Neutral Signals
Tracked Macro Signals for VRTX
Signal Category Current Status
FDA Drug Approval Velocity (openFDA) Healthcare & Biotech ● Neutral
High-Yield Credit Spread (ICE BofA) Macro & Liquidity ▲ Bullish
10-Year Treasury Yield Macro & Liquidity ▼ Bearish

See VRTX's live macro context

Unstructured Alpha maps the 3 macro factors that actually matter for VRTX and flags when the backdrop around it changes — with per-signal contribution and honest coverage, not a black-box number.

See why VRTX's factors moved →

Scores are derived from macro signals (FRED, EIA, SEC filings, FINRA short interest) and updated as new data arrives. This is not financial advice. Past signal accuracy does not guarantee future results.
unstructuredalpha.com · Not financial advice